Inventor · disambiguated record
A. Scott Muerhoff
Also filed as: MUERHOFF A SCOTT
13 granted patents·6 pending applications·96 citations·filing 1996–2022
90Inventor score
Top patents by PatentIndex Score
19 records- 0195US9194873B2HCV antigen-antibody combination assay and methods and compositions for use thereinABBOTT LAB·Filed 2013·Granted Nov 24, 2015·19 cites·13 claims
- 0291US6727092B2Methods for the simultaneous detection of HCV antigens and HCV antibodiesABBOTT LAB·Filed 2002·Granted Apr 27, 2004·33 cites·4 claims
- 0386US9841427B2HCV antigen-antibody combination assay and methods and compositions for use thereinABBOTT LAB·Filed 2015·Granted Dec 12, 2017·3 cites·4 claims
- 0486US9371374B2HCV core lipid binding domain monoclonal antibodiesABBOTT LAB·Filed 2013·Granted Jun 21, 2016·4 cites·16 claims
- 0586US6855809B2Methods for the simultaneous detection of HCV antigens and HCV antibodiesABBOTT LAB·Filed 2004·Granted Feb 15, 2005·15 cites·4 claims
- 0684US6455255B1Method of performing subtractive hybridization using RDAABBOTT LAB·Filed 2000·Granted Sep 24, 2002·13 cites·8 claims
- 0777US9790478B2HCV NS3 recombinant antigens and mutants thereof for improved antibody detectionABBOTT LAB·Filed 2013·Granted Oct 17, 2017·3 cites·29 claims
- 0875US11428694B2Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodiesABBOTT LAB·Filed 2021·Granted Aug 30, 2022·0 cites·9 claims
- 0971US2020141937A1Detection methods employing hcv core lipid and dna binding domain monoclonal antibodiesABBOTT LAB·Filed 2019·Application pending·0 cites
- 1068US2020033344A1Detection methods employing hcv core lipid and dna binding domain monoclonal antibodiesABBOTT LAB·Filed 2019·Application pending·0 cites
- 1162US10345311B2Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodiesABBOTT LAB·Filed 2016·Granted Jul 9, 2019·0 cites·12 claims
- 1262US10197573B2HCV core lipid binding domain monoclonal antibodiesABBOTT LAB·Filed 2016·Granted Feb 5, 2019·0 cites·18 claims
- 1360US10444242B2Detection methods employing HCV core lipid and DNA binding domain monoclonal antibodiesABBOTT LAB·Filed 2016·Granted Oct 15, 2019·0 cites·8 claims
- 1455US2023258638A1Methods and kits for detecting or determining an amount of an anti-b-coronavirus antibody in a sampleABBOTT LAB·Filed 2022·Application pending·0 cites
- 1552US2001041331A1Methods of utilizing the TT virusFiled 2001·Application pending·0 cites
- 1651US2022043000A1Methods and kits for detecting sars-cov-2 protein in a sampleABBOTT LAB·Filed 2021·Application pending·0 cites
- 1750US2017327803A1Hcv ns3 recombinant antigens and mutants thereof for improved antibody detectionABBOTT LAB·Filed 2017·Application pending·0 cites
- 1843US5709997ANucleic acid detection of hepatitis GB virusABBOTT LAB·Filed 1996·Granted Jan 20, 1998·6 cites·30 claims
- 1936US9551714B2Materials and methods for assay of anti-hepatitis C virus (HCV) antibodiesLEARY THOMAS P·Filed 2011·Granted Jan 24, 2017·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when A. Scott Muerhoff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →